Menstrual cycle and reproductive aging alters immune reactivity, NGF expression, antioxidant enzyme activities, and intracellular signaling pathways in the peripheral blood mononuclear cells of healthy women

Brain, Behavior, and Immunity

Volumn 32, Issue , 2013, Pages 131-143

  Priyanka, Hannah P ^a   Sharma, Utsav ^a   Gopinath, Srinivasan ^a   Sharma, Varun ^a   Hima, Lalgi ^a   ThyagaRajan, Srinivasan ^a  

^a SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Akt; CREB; Cytokine; ERK; Estrogen; Menopause; NF B; Nitric oxide; Progesterone

Indexed keywords

CATALASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTRADIOL; ESTROGEN; GAMMA INTERFERON; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NITRIC OXIDE; PROGESTERONE; SUPEROXIDE DISMUTASE;

ADULT; AGING; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ESTROGEN BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; LUTEAL PHASE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; T LYMPHOCYTE; YOUNG ADULT;

EID: 84891373326     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.03.008     Document Type: Article

References (55)

1. Amantea, D., Russo, R., Bagetta, G., Corasaniti, M.T., 2005. From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol. Res. 52, 119-132.
2. Antonelli, A., Bracci-Laudiero, L., Aloe, L., 2003. Altered plasma nerve growth factorlike immunoreactivity and nerve growth factor-receptor expression in human old age. Gerontology 49, 185-190.
3. Bellinger, D.L., Madden, K.S., Lorton, D., ThyagaRajan, S., Felten, D.L., 2001. Agerelated alterations in neural-immune interactions and neural strategies in immunosenescence. In: Ader, R., Felten, D.L., Cohen, N. (Eds.), Psychoneuroimmunology, 1. Academic Press, San Diego, pp. 241-288.
4. Bruunsgaard, H., Pedersen, M., Pedersen, B.K., 2001. Aging and proinflammatory cytokines. Curr. Opin. Hematol. 8, 131-136.
5. Chen, Y., Gorelik, G.J., Strickland, F.M., Richardson, B.C., 2010. Decreased ERK and JNK signaling contribute to gene overexpression in senescent CD4+ CD28-T cells through epigenetic mechanisms. J. Leukoc. Biol. 87, 137-145.
6. Chin, J.H., Okazaki, M., Frazier, J.S., Hu, Z.W., Hoffman, B.B., 1996. Impaired cAMPmediated gene expression and decreased cAMP response element binding protein in senescent cells. Am. J. Physiol. 271, C362-C371.
7. Correale, J., Arias, M., Gilmore, W., 1998. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 161, 3365-3374.
8. Cignarella, A., Kratz, M., Bolego, C., 2010. Emerging role of estrogen in the control of cardiometabolic disease. Trends Pharmacol. Sci. 31, 183-189.
9. Davila, D.R., Kelley, K.W., 1988. Sex differences in lectin-induced interleukin-2 synthesis in aging rats. Mech. Ageing Dev. 44, 231-240.
10. De la Fuente, M., Hernanz, A., Vallejo, M.C., 2005. The immune system in the oxidative stress conditions of aging and hypertension: favorable effects of antioxidants and physical exercise. Antioxid. Redox Signal. 7, 1356-1366.
11. Ellman, G.L., 1959. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82, 70-77.
12. Faas, M., Bouman, A., Moesa, H., Heineman, M.J., de Leij, L., Schuiling, G., 2000. The immune response during the luteal phase of the ovarian cycle: a Th2-type response? Fertil. Steril. 74, 1008-1013.
13. Fiddler, R.N., 1977. Collaborative study of modified AOAC method of analysis for nitrite in meat and meat products. J. Assoc. Off. Anal. Chem. 60, 594-599.
14. Gameiro, C.M., Romão, F., Castelo-Branco, C., 2010. Menopause and aging: changes in the immune system-a review. Maturitas 67, 316-320.
15. Gautam, N., Das, S., Mahapatra, S.K., Chakraborty, S.P., Kundu, P.K., Roy, S., 2010. Age associated oxidative damage in lymphocytes. Oxid. Med. Cell. Longev. 3, 275-282.
16. González, D.A., Díaz, B.B., Rodríguez Pérez Mdel, C., Hernández, A.G., Chico, B.N., de León, A.C., 2010. Sex hormones and autoimmunity. In: Immunol. Lett. 133, 6-13.
17. Góth, L., 1991. A simple method for determination of serum catalase activity and revision of reference range. Clin. Chim. Acta 196, 143-151.
18. Grolleau-Julius, A., Ray, D., Yung, R.L., 2010. The role of epigenetics in aging and autoimmunity. Clin. Rev. Allergy Immunol. 39, 42-50.
19. Gupta, S., Bi, R., Kim, C., Chiplunkar, S., Yel, L., Gollapudi, S., 2005. Role of NF-kappaB signaling pathway in increased tumor necrosis factor-alpha-induced apoptosis of lymphocytes in aged humans. Cell Death Differ. 12, 177-183.
20. Habig, W.H., Pabst, M.J., Jakoby, W.B., 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249, 7130-7139.
21. Janicki, S.C., Schupf, N., 2010. Hormonal influences on cognition and risk for Alzheimer's disease. Curr. Neurol. Neurosci. Rep. 10, 359-566.
22. Kane, L.P., Andres, P.G., Howland, K.C., Abbas, A.K., Weiss, A., 2001. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines. Nat. Immunol. 2 (1), 37-44.
23. Khosla, S., Melton 3rd, L.J., Atkinson, E.J., O'Fallon, W.M., Klee, G.G., Riggs, B.L., 1998. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. In: J. Clin. Endocrinol. Metab. 83, 2266-2274.
24. Kitaura, J., Asai, K., Maeda-Yamamoto, M., Kawakami, Y., Kikkawa, U., Kawakami, T., 2000. Akt dependent cytokine production in Mast cells. J. Exp. Med. 192 (5), 729-740.
25. Koike, E., Kobayashi, T., Mochitate, K., Murakami, M., 1999. Effect of aging on nitric oxide production by rat alveolar macrophages. Exp. Gerontol. 34, 889-894.
26. Kovacs, E.J., Plackett, T.P., Witte, P.L., 2004. Estrogen replacement, aging, and cellmediated immunity after injury. J. Leukoc. Biol. 76 (1), 36-41.
27. Larbi, A., Dupuis, G., Khalil, A., Douziech, N., Fortin, C., Fülöp Jr., T., 2006. Differential role of lipid rafts in the functions of CD4+ and CD8+ human T lymphocytes with aging. Cell. Signal. 18, 1017-1030.
28. Larbi, A., Franceschi, C., Mazzatti, D., Solana, R., Wikby, A., Pawelec, G., 2008. Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda) 23, 64-74.
29. Linker, R., Gold, R., Luhder, F., 2009. Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination. Crit. Rev. Immunol. 29, 43-68.
30. Manolagas, S.C., 2010. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr. Rev. 31, 266-300.
31. Miquel, J., Ramírez-Boscá, A., Ramírez-Bosca, J.V., Alperi, J.D., 2006. Menopause: a review on the role of oxygen stress and favorable effects of dietary antioxidants. Arch. Gerontol. Geriatr. 42, 289-306.
32. MohanKumar, P.S., ThyagaRajan, S., Quadri, S.K., 1994. Correlations of catecholamine release in the medial preoptic area with proestrous surges of luteinizing hormone and prolactin: effects of aging. Endocrinology 135, 119-126.
33. Mohankumar, P.S., Thyagarajan, S., Quadri, S.K., 1995. Cyclic and age-related changes in norepinephrine concentrations in the medial preoptic area and arcuate nucleus. Brain Res. Bull. 38, 561-564.
34. Mohankumar, P.S., Thyagarajan, S., Quadri, S.K., 1997. Tyrosine hydroxylase and DOPA decarboxylase activities in the medical preoptic area and arcuate nucleus during the estrous cycle: effects of aging. Brain Res. Bull. 42, 265-271.
35. Morgan, B., Thorpe, L.W., Marchetti, D., Perez-Polo, J.R., 1989. Expression of nerve growth factor receptors by human peripheral blood mononuclear cells. J. Neurosci. Res. 23, 41-45.
36. Neal-Perry, G., Nejat, E., Dicken, C., 2010. The neuroendocrine physiology of female reproductive aging: an update. Maturitas 67, 34-38.
37. Oertelt-Prigione, S., 2012. Immunology and the menstrual cycle. Autoimmun. Rev. 11, A486-A492.
38. Olsen, N.J., Kovacs, W.J., 1996. Gonadal steroids and immunity. Endocr. Rev. 17, 369-384.
39. Pahlavani, M.A., Richardson, A., 1996. The effect of age on the expression of interleukin-2. Mech. Ageing Dev. 89, 125-154.
40. Pluchino, N., Cubeddu, A., Begliuomini, S., Merlini, S., Giannini, A., Bucci, F., et al., 2009. Daily variation of brain-derived neurotrophic factor and cortisol in women with normal menstrual cycles, undergoing oral contraception and in postmenopause. Hum. Reprod. 24, 2303-2309.
41. Priyanka, H.P., Bala, P., Ankisettipalle, S., ThyagaRajan, S., 2013a. Bacopa monnieri and L-deprenyl differentially enhance the activities of antioxidant enzymes and the expression of tyrosine hydroxylase and nerve growth factor via ERK 1/2 and NF-κB pathways in the spleen of female Wistar rats. Neurochem. Res. 38, 141-152.
42. Priyanka, H.P., Singh, R.V., Mishra, M., Thyagarajan, S., 2013b. Diverse age-related effects of Bacopa monnieri and donepezil in vitro on cytokine production, antioxidant enzyme activities, and intracellular targets in splenocytes of F344 male rats. Int. Immunopharmacol. 15, 260-274.
43. Randolph Jr., J.F., Sowers, M., Bondarenko, I.V., Harlow, S.D., Luborsky, J.L., Little, R.J., 2004. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J. Clin. Endocrinol. Metab. 89, 1555-1561.
44. Rannevik, G., Jeppsson, S., Johnell, O., Bjerre, B., Laurell-Borulf, Y., Svanberg, L., 1995. Longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. In: Maturitas 21, 103-113.
45. Reddy, K.K., Reddy, T.P., Somasekharaiah, B.V., Kumar, K.S., 1998. Changes in antioxidant enzyme levels and DNA damage during aging. Indian J. Clin. Biochem. 13, 20-26.
46. Sherman, B.M., West, J.H., Korenman, S.G., 1976. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J. Clin. Endocrinol. Metab. 42, 629-636.
47. Strehlow, K., Rotter, S., Wassmann, S., Adam, O., Grohé, C., Laufs, K., et al., 2003. Modulation of antioxidant enzyme expression and function by estrogen. Circ. Res. 93, 170-177.
48. Sun, M., Zigman, S., 1978. An improved spectrophotometric assay for superoxide dismutase based on epinephrine autoxidation. Anal. Biochem. 90, 81-89.
49. SEER database., 2012. SEER Stat fact sheets: breast. Available http://seer.cancer.gov/statfacts/html/breast.html.
50. Taddei, S., Virdis, A., Ghiadoni, L., Salvetti, G., Bernini, G., Magagna, A., et al., 2001. Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38, 274-279.
51. ThyagaRajan, S., MohanKumar, P.S., Quadri, S.K., 1995. Cyclic changes in the release of norepinephrine and dopamine in the medial basal hypothalamus: effects of aging. Brain Res. 689, 122-128.
52. ThyagaRajan, S., Felten, D.L., 2002. Modulation of neuroendocrine-immune signaling by L-deprenyl and L-desmethyldeprenyl in aging and mammary cancer. Mech. Ageing Dev. 123, 1065-1079.
53. ThyagaRajan, S., Madden, K.S., Teruya, B., Stevens, S.Y., Felten, D.L., Bellinger, D.L., 2011. Age-associated alterations in sympathetic noradrenergic innervation of primary and secondary lymphoid organs in female Fischer 344 rats. J. Neuroimmunol. 233, 54-64.
54. Wise, P.M., Smith, M.J., Dubal, D.B., Wilson, M.E., Rau, S.W., Cashion, A.B., et al., 2002. Neuroendocrine modulation and repercussions of female reproductive aging. Recent Prog. Horm. Res. 57, 235-256.
55. Yagi, K., 1976. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15, 212-216.